Table 1.

Cohort details.

Case ID (n = 23)	Age	Sex	Status	Cause of death	Disease duration (years)	PMI (hours)	Brain pH	Fixation (months)	CDR	ABC score	AD likelihood b	APOE genotype
M01	69	Male	Control	Cardiac failure	–	16	6.6	97	–	A3 B1 C3	Low	E3/E4
M02	74	Female	Control	Cancer	–	20	6.59	19	–	A3 B1 C3	Low	E3/E4
M03	76	Female	AD	Cardiorespiratory failure	11	3	5.98	35	3	A3 B2 C3	Intermediate	E3/E4
M04	77	Male	AD	Aspiration pneumonia	9	26	6.34	12	2	A3 B3 C2	High	E4/E4
M05	78	Female	Control	Respiratory failure	–	11	6.3	78	–	A0 B0 C0	Low	E3/E3
M06	78	Female	Control	Toxicity	–	45	6.05	58	–	A0 B1 C0	Low	E3/E4
M07	81	Male	Control	Cardiac failure	–	29	6.57	26	–	A0 B2 C0	Low	E3/E3
M08	80	Male	Control	Respiratory failure	–	12	6.5	9	–	A0 B0 C0	Low	E3/E3
M09	80	Female	AD	Alzheimer's disease	10	32	6.54	25	3	A3 B3 C3	High	E3/E4
M10	82	Female	Control	Respiratory failure	–	7.5	6.45	102	–	A3 B1 C2	Low	E3/E3
M11	83	Male	AD	Cerebrovascular	5	25	6.26	70	3	A3 B3 C3	High	E4/E4
M12	83	Female	AD	Uraemia	7	3	5.88	61	3	A3 B3 C2	High	E3/E4
M13	84	Female	AD	Aspiration pneumonia	13	6	6.32	64	3	A3 B3 C3	High	E3/E4
M14 a	85	Male	Control	Cancer	–	9	6.57	61	–	A2 B2 C3	Intermediate	E3/E3
M15	85	Female	Control	Respiratory failure	–	10	6.63	34	–	A2 B1 C0	Low	E3/E3
M16	85	Female	Control	Pneumonia	–	23	6.44	73	0	A2 B0 C1	Low	E3/E3
M17	85	Female	AD	Cardiorespiratory failure	5	10	5.91	15	3	A3 B3 C3	High	E3/E3
M18 a	87	Female	Control	Cancer	–	5	6.38	34	–	A2 B2 C0	Intermediate	E3/E4
M19 a	92	Female	Control	Pancytopenia	–	5	6.08	34	0	A2 B2 C2	Intermediate	E3/E3
M20	93	Female	Control	Cardiac failure	–	21	6.96	81	0.5	A1 B0 C0	Low	E3/E3
M21 a	87	Female	Control	Acute peritonitis	–	24	–	–	0	A3 B2 C1	Intermediate	–
M22	98	Female	AD	Cerebrovascular	6	11	6.11	18	3	A3 B3 C2	High	E3/E3
M23 a	102	Female	Control	Acute renal failure	–	5	5.92	35	0	A2 B2 C2	Intermediate	E2/E3

^aHigh‐pathology controls.

^bAs per NIA‐AA diagnostic criteria 35.